<DOC>
	<DOCNO>NCT01557010</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety administer DWP05195 Postherpetic Neuralgia .</brief_summary>
	<brief_title>Evaluate Efficacy Safety DWP05195 Subjects With Post-Herpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Male Female subject age 20 80 year Subjects symptoms neuropathic pain associate postherpetic neuralgia ( PHN ) . Subjects must pain present &gt; 3 month heal acute herpes zoster skin rash . Other severe pain may potentially confound pain assessment . Subjects symptoms neuropathic pain apply Medical Equipment Within 2 year : Subjects diagnose cancer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>